The Valley Desk

NCT03769467 · Interventional trial

Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Epstein-Barr Viraemia, Epstein-Barr Virus Infections, Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC), Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov